Navigation Links
Bad driving may have genetic basis, UCI study finds

Irvine, Calif., Oct. 28, 2009 Bad drivers may in part have their genes to blame, suggests a new study by UC Irvine neuroscientists.

People with a particular gene variant performed more than 20 percent worse on a driving test than people without it and a follow-up test a few days later yielded similar results. About 30 percent of Americans have the variant.

"These people make more errors from the get-go, and they forget more of what they learned after time away," said Dr. Steven Cramer, neurology associate professor and senior author of the study published recently in the journal Cerebral Cortex.

This gene variant limits the availability of a protein called brain-derived neurotrophic factor during activity. BDNF keeps memory strong by supporting communication among brain cells and keeping them functioning optimally. When a person is engaged in a particular task, BDNF is secreted in the brain area connected with that activity to help the body respond.

Previous studies have shown that in people with the variant, a smaller portion of the brain is stimulated when doing a task than in those with a normal BDNF gene. People with the variant also don't recover as well after a stroke. Given these differences, the UCI scientists wondered: Could the variant affect an activity such as driving?

"We wanted to study motor behavior, something more complex than finger-tapping," said Stephanie McHughen, graduate student and lead author of the study. "Driving seemed like a good choice because it has a learning curve and it's something most people know how to do."

The driving test was taken by 29 people 22 without the gene variant and seven with it. They were asked to drive 15 laps on a simulator that required them to learn the nuances of a track programmed to have difficult curves and turns. Researchers recorded how well they stayed on the course over time. Four days later, the test was repeated.

Results showed that people with the variant did worse on both tests than the other participants, and they remembered less the second time. "Behavior derives from dozens and dozens of neurophysiologic events, so it's somewhat surprising this exercise bore fruit," Cramer said.

The gene variant isn't always bad, though. Studies have found that people with it maintain their usual mental sharpness longer than those without it when neurodegenerative diseases such as Parkinson's, Huntington's and multiple sclerosis are present.

"It's as if nature is trying to determine the best approach," Cramer said. "If you want to learn a new skill or have had a stroke and need to regenerate brain cells, there's evidence that having the variant is not good. But if you've got a disease that affects cognitive function, there's evidence it can act in your favor. The variant brings a different balance between flexibility and stability."

A test to determine whether someone has the gene variant is not commercially available.

"I'd be curious to know the genetics of people who get into car crashes," Cramer said. "I wonder if the accident rate is higher for drivers with the variant."


Contact: Jennifer Fitzenberger
University of California - Irvine

Related biology news :

1. Climate change driving Michigan mammals north
2. Telescope embedded in glasses lens promises to make driving easier for visually impaired
3. Destruction of Sumatra forests driving global climate change and species extinction
4. The race for biofuels driving alternative sources of biomass
5. Extended wakefulness, combined with alcohol, severely impairs driving performance
6. Alcohol and sleep restriction can affect young mens alertness and driving performance
7. Scientists demonstrate link between genetic defect and brain changes in schizophrenia
8. Chemist receives NIH New Innovator grant for genetic drug research
9. CHEO RI study uses sophisticated genetic engineering to improve insulin-producing beta cells
10. East African cichlid fish offer new understanding of genetic basis of sex determination
11. Genetic conflict in fish led to evolution of new sex chromosomes
Post Your Comments:
(Date:11/11/2015)... MedNet Solutions , an innovative SaaS-based eClinical technology company that ... announce that it will be a Sponsor of the ... held November 17-19 in Hamburg , Germany.  ... iMedNet , MedNet,s easy-to-use, proven and affordable eClinical ... able to deliver time and cost savings of up to ...
(Date:11/9/2015)... JOSE, Calif. , Nov. 9, 2015  Synaptics ... human interface solutions, today announced broader entry into the ... vehicle-specific solutions that match the pace of consumer electronics ... and biometric sensors are ideal for the automotive industry ... vehicle. Europe , ...
(Date:10/29/2015)... Calif. , Oct. 29, 2015  The J. ... new report titled, "DNA Synthesis and Biosecurity: Lessons Learned ... the Department of Health and Human Services guidance for ... in 2010. --> ... it also has the potential to pose unique biosecurity ...
Breaking Biology News(10 mins):
(Date:11/30/2015)... Zenith Epigenetics Corp. ("Zenith" or the "Company") today announced that ... its Board of Directors to replace Dr. Peter Johann ... experience as co-founder of Resverlogix, with expertise in the fields ... --> Dr. Wong remarked, "I am very excited ... standing expertise in epigenetics and the advanced stage of the ...
(Date:11/30/2015)... , Nov. 30, 2015  Champions Oncology, Inc. (CSBR), ... services to personalize the development and use of oncology ... Executive Officer, will be presenting at the LD MICRO ... Pacific Standard Time (PST).  The conference, held at the ... Angeles, CA , will feature 200 small/micro-cap companies ...
(Date:11/30/2015)... 2015  HUYA Bioscience International, the leader in accelerating ... innovations, today announced it has signed a Memorandum of ... foster collaboration between KDDF and HUYA with the ultimate ... products for the global market. ... new innovative preclinical and clinical stage compounds. The company ...
(Date:11/30/2015)... Germany , November 30, 2015 ... Vienna, Austria to be held December ... (ECNR) in Vienna, Austria to ... wholly owned subsidiary of Vycor Medical, Inc. ("Vycor") (OTCQB: VYCO), ... NovaVision Therapy Suite at the 3rd European Congress of ...
Breaking Biology Technology: